看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 4.6x - 5.1x | 4.8x |
| Selected Fwd Revenue Multiple | 3.7x - 4.0x | 3.9x |
| Fair Value | ﷼137.20 - ﷼151.45 | ﷼144.33 |
| Upside | -11.3% - -2.0% | -6.6% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Middle East Healthcare Company | 4009 | SASE:4009 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 4017 | SASE:4017 |
| Mouwasat Medical Services Company | 4002 | SASE:4002 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| National Medical Care Company | 4005 | SASE:4005 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 4009 | 4017 | 4002 | 4007 | 4013 | 4005 | |||
| SASE:4009 | SASE:4017 | SASE:4002 | SASE:4007 | SASE:4013 | SASE:4005 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 14.0% | 11.2% | 9.2% | 3.4% | 17.4% | 12.8% | ||
| 3Y CAGR | 15.5% | 12.4% | 10.3% | 6.6% | 15.6% | 15.2% | ||
| Latest Twelve Months | 8.7% | 20.0% | 6.4% | -1.9% | 17.8% | 19.6% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 8.3% | 15.7% | 27.9% | 21.3% | 20.3% | 19.2% | ||
| Prior Fiscal Year | 12.2% | 14.4% | 28.0% | 29.1% | 22.0% | 22.8% | ||
| Latest Fiscal Year | 15.3% | 12.9% | 25.1% | 26.5% | 21.0% | 19.7% | ||
| Latest Twelve Months | 15.3% | 12.9% | 25.1% | 26.5% | 21.0% | 19.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 2.99x | 4.30x | 5.28x | 5.66x | 9.26x | 5.30x | ||
| EV / LTM EBIT | 19.6x | 33.4x | 21.0x | 21.3x | 44.0x | 26.9x | ||
| Price / LTM Sales | 2.14x | 4.04x | 5.14x | 5.73x | 8.75x | 5.36x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 2.99x | 5.28x | 9.26x | |||||
| Historical EV / LTM Revenue | 2.76x | 3.70x | 6.98x | |||||
| Selected EV / LTM Revenue | 4.58x | 4.82x | 5.06x | |||||
| (x) LTM Revenue | 1,294 | 1,294 | 1,294 | |||||
| (=) Implied Enterprise Value | 5,924 | 6,236 | 6,548 | |||||
| (-) Non-shareholder Claims * | 79 | 79 | 79 | |||||
| (=) Equity Value | 6,003 | 6,315 | 6,627 | |||||
| (/) Shares Outstanding | 44.9 | 44.9 | 44.9 | |||||
| Implied Value Range | 133.85 | 140.80 | 147.76 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 133.85 | 140.80 | 147.76 | 154.60 | ||||
| Upside / (Downside) | -13.4% | -8.9% | -4.4% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4009 | 4017 | 4002 | 4007 | 4013 | 4005 | |
| Enterprise Value | 8,568 | 11,993 | 15,195 | 6,532 | 103,247 | 6,855 | |
| (+) Cash & Short Term Investments | 52 | 534 | 512 | 245 | 2,891 | 567 | |
| (+) Investments & Other | 60 | 196 | 0 | 135 | 465 | 0 | |
| (-) Debt | (2,466) | (1,078) | (762) | (304) | (8,165) | (488) | |
| (-) Other Liabilities | (48) | (374) | (145) | 0 | (438) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,167 | 11,270 | 14,800 | 6,608 | 98,000 | 6,934 | |
| (/) Shares Outstanding | 92.0 | 230.0 | 200.0 | 160.0 | 350.0 | 44.9 | |
| Implied Stock Price | 67.00 | 49.00 | 74.00 | 41.30 | 280.00 | 154.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 67.00 | 49.00 | 74.00 | 41.30 | 280.00 | 154.60 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |